AN EMAIL THAT MANY OF YOU ARE RECEIVING. HERE’S THE EMAIL CONCERNING THE EQUIFAX DATA BREACH SETTLEMENT INFORMING YOU THAT YOU ARE ELIGIBLE FOR AN ADDITIONAL PAYMENT. THAT PAYMENT WILL ARRIVE IN THE ...
archTIS Ltd, a global provider of data-centric software solutions for the secure collaboration of sensitive information, has completed its acquisition of U.S.-based Spirion LLC, a leading provider of ...
Sanofi says that its experimental drug amlitelimab has the potential to become a ‘best-in-class’ maintenance therapy for atopic dermatitis (AD) after reporting new phase 2b data. The latest results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback